Join the Neoantigen Based Therapies Summit to Revolutionize
Commercialization of Neoantigen Cancer Vaccines!
The 7th Neoantigen Based Therapies Summit is the leading industry-dedicated meeting that supercharges the engineering of personalised neoantigen & shared antigen vaccines through robust prediction, enhanced identification, and critical validation to improve the accessibility and efficacy of patient care.
What you can expect...
- 100+ Attendees
- 30+ World-Class Speakers
- 20+ Late-Breaking Presentations
- 10+ Hours Networking
- 2 Workshops for Pre-Conference Day
Download your own copy of the brochure here to see the full 3-day program of unrivalled content.
“A great opportunity to exchange ideas with top research of the most innovative and promising cancer therapies developed around the concept of neoantigens.”